Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Woll

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Thorax|December 1, 1991
New perspectives in lung cancer. 2. Growth factors and lung cancerP J Woll
Journal of the Royal College of Physicians of London|January 1, 1987
Who treats cancer?P J Woll
British Journal of Cancer|March 1, 1991
Neuropeptide growth factors and cancerP J Woll
BMJ (Clinical Research Ed.)|December 5, 1998
Smoking and risk of myocardial infarction. Smoking is a feminist issueP J Woll
Journal of the Royal Society of Medicine|November 1, 1993
Growth factors, antagonists and lung cancerP J Woll
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitroP J Woll, E Rozengurt
Growth Factors (Chur, Switzerland)|January 1, 1988
Two classes of antagonist interact with receptors for the mitogenic neuropeptides bombesin, bradykinin, and vasopressinP J Woll, E Rozengurt
British Medical Bulletin|April 1, 1989
Neuropeptides as growth regulatorsP J Woll, E Rozengurt
The British Journal of Clinical Practice|March 1, 1997
Interferons in oncologyP J Woll, R Pettengell
Cancer Treatment and Research|January 1, 1995
Growth factors and lung cancerT Sethi, P J Woll
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Thorax|December 1, 1991
New perspectives in lung cancer. 2. Growth factors and lung cancerP J Woll
Journal of the Royal College of Physicians of London|January 1, 1987
Who treats cancer?P J Woll
British Journal of Cancer|March 1, 1991
Neuropeptide growth factors and cancerP J Woll
BMJ (Clinical Research Ed.)|December 5, 1998
Smoking and risk of myocardial infarction. Smoking is a feminist issueP J Woll
Journal of the Royal Society of Medicine|November 1, 1993
Growth factors, antagonists and lung cancerP J Woll
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitroP J Woll, E Rozengurt
Growth Factors (Chur, Switzerland)|January 1, 1988
Two classes of antagonist interact with receptors for the mitogenic neuropeptides bombesin, bradykinin, and vasopressinP J Woll, E Rozengurt
British Medical Bulletin|April 1, 1989
Neuropeptides as growth regulatorsP J Woll, E Rozengurt
The British Journal of Clinical Practice|March 1, 1997
Interferons in oncologyP J Woll, R Pettengell
Cancer Treatment and Research|January 1, 1995
Growth factors and lung cancerT Sethi, P J Woll
Pageof 7